118 results
10QSB
2008 Q2
ABVC
ABVC BioPharma Inc
14 Aug 08
Quarterly report (small business)
12:00am
Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133”. This statement changes the disclosure requirements for derivative … instruments and hedging activities. SFAS 161 will become effective for the Company beginning in the three months ending March 31, 2009. The adoption
8-K
EX-10.2
ABVC
ABVC BioPharma Inc
14 Apr 20
American BriVision Announces Two Financial Transactions To Improve Working Capital and Reduce Debt
3:45pm
hedging transaction with respect to the Securities, including without limitation, any put, call or other option transaction, option writing or equity … , OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. “
(4
8-K
EX-10.1
ABVC
ABVC BioPharma Inc
24 Apr 20
Entry into a Material Definitive Agreement
4:05pm
not in the United States, engaged in, and prior to the expiration of the Restricted Period will not engage in, any short selling of or any hedging … , OR PURSUANT TO AVAILABLE EXEMPTION FROM REGISTRATION. HEDGING TRANSACTIONS MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT. “
(4
10-Q
3g6xq jn9vwl
11 Feb 09
Quarterly report
12:00am
8-K/A
EX-99.1
vh0 f8u26
26 Jan 24
Report of Independent Registered Public Accounting Firm
12:00am
10QSB
2fivyfo
20 May 08
Quarterly report (small business)
12:00am
S-1
dxfn0s8c2ft
23 Jun 09
IPO registration
12:00am
8-K
EX-10.1
bjdv5 0mi8
17 Nov 20
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
snnv5z1f80a4
5 Nov 20
Entry into a Material Definitive Agreement
4:25pm
10-K/A
etflczkh x8m7a
11 Feb 10
Annual report (amended)
12:00am
8-K
EX-10.1
95qoptm
27 Jul 23
Entry into a Material Definitive Agreement
9:14am